1. Wang, Jing, Kang, Zijian, Liu, Yandong, Liu, Yang, Liu, Jianmin. 2022. Identification of immune cell infiltration and diagnostic biomarkers in unstable atherosclerotic plaques by integrated bioinformatics analysis and machine learning. In Frontiers in immunology, 13, 956078. doi:10.3389/fimmu.2022.956078. https://pubmed.ncbi.nlm.nih.gov/36211422/
2. Li, Lei, Fei, Yinjiao, Dong, Tianfu, Liang, Mingxing, Tang, Jinhai. 2024. IFI30 as a key regulator of PDL1 immunotherapy prognosis in breast cancer. In International immunopharmacology, 133, 112093. doi:10.1016/j.intimp.2024.112093. https://pubmed.ncbi.nlm.nih.gov/38669947/
3. Jiang, Wei, Zheng, Feifei, Yao, Taotao, Zheng, Wenjie, Yao, Ninghua. . IFI30 as a prognostic biomarker and correlation with immune infiltrates in glioma. In Annals of translational medicine, 9, 1686. doi:10.21037/atm-21-5569. https://pubmed.ncbi.nlm.nih.gov/34988195/
4. Liu, Xiu, Song, Chunyan, Yang, Shoubo, Chen, Feng, Li, Wenbin. 2020. IFI30 expression is an independent unfavourable prognostic factor in glioma. In Journal of cellular and molecular medicine, 24, 12433-12443. doi:10.1111/jcmm.15758. https://pubmed.ncbi.nlm.nih.gov/32969157/
5. Yang, Jian, Yang, Shenghe, Cai, Jinlian, Ma, Jie, Ge, Jianwei. 2023. A Transcription Factor ZNF384, Regulated by LINC00265, Activates the Expression of IFI30 to Stimulate Malignant Progression in Glioma. In ACS chemical neuroscience, 15, 290-299. doi:10.1021/acschemneuro.3c00562. https://pubmed.ncbi.nlm.nih.gov/38141017/
6. Fan, Yan, Wang, Xu, Li, Yang. 2021. IFI30 expression predicts patient prognosis in breast cancer and dictates breast cancer cells proliferation via regulating autophagy. In International journal of medical sciences, 18, 3342-3352. doi:10.7150/ijms.62870. https://pubmed.ncbi.nlm.nih.gov/34400904/
智鼠故事 
